Showing results (101-110 of 362) with videos related to

Sort By:
Pageof 37
Annals of Internal Medicine|August 2, 2016
Bioequivalence of Biosimilar Tumor Necrosis Factor-α Inhibitors Compared With Their Reference Biologics: A Systematic ReviewFrancine Chingcuanco, Jodi B Segal, Seoyoung C Kim, et al.
Journal of the American Geriatrics Society|February 7, 2022
Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative surveyMichael J DiStefano, G Caleb Alexander, Daniel Polsky, et al.
Plos Medicine|September 26, 2025
Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort studyJingjing Sun, Hemalkumar B Mehta, Jodi B Segal, et al.
PLOS Global Public Health|December 19, 2025
Screening, brief intervention, and referral to treatment training for Nigerian primary care physicians: A pilot evaluation of knowledge, attitudes, self-efficacy, and barriers to implementationHonest Anaba, Johannes Thrul, Elohor Oborevwori, et al.
Medical Care|January 11, 2023
Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel FrameworkBrendan Saloner, Hsien-Yen Chang, G Caleb Alexander, et al.
Epidemiologic Reviews|January 29, 2021
The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related HarmsChristopher M Jones, Faraah Bekheet, Ju Nyeong Park, et al.
The American Journal of Emergency Medicine|February 25, 2014
Prevalence and treatment of pain in EDs in the United States, 2000 to 2010Hsien-Yen Chang, Matthew Daubresse, Stefan P Kruszewski, et al.
JAMA Health Forum|January 19, 2024
Recreational and Medical Cannabis Legalization and Opioid Prescriptions and MortalityHai V Nguyen, Emma E McGinty, Shweta Mital, et al.
Health Affairs (Project Hope)|December 3, 2024
More US Pharmacies Closed Than Opened In 2018-21; Independent Pharmacies, Those In Black, Latinx Communities Most At RiskJenny S Guadamuz, G Caleb Alexander, Genevieve P Kanter, et al.
JAMA Internal Medicine|August 15, 2018
Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 DiabetesHsien-Yen Chang, Sonal Singh, Omar Mansour, et al.
Pageof 37